Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Clinics ; 69(10): 660-665, 10/2014. tab, graf
Article in English | LILACS | ID: lil-730460

ABSTRACT

OBJECTIVE: Ovarian mucinous metastases commonly present as the first sign of the disease and are capable of simulating primary tumors. Our aim was to investigate the role of intratumoral lymphatic vascular density together with other surgical-pathological features in distinguishing primary from secondary mucinous ovarian tumors. METHODS: A total of 124 cases of mucinous tumors in the ovary (63 primary and 61 metastatic) were compared according to their clinicopathological features and immunohistochemical profiles. The intratumoral lymphatic vascular density was quantified by counting the number of vessels stained by the D2-40 antibody. RESULTS: Metastases occurred in older patients and were associated with a higher proportion of tumors smaller than 10.0 cm; bilaterality; extensive necrosis; extraovarian extension; increased expression of cytokeratin 20, CDX2, CA19.9 and MUC2; and decreased expression of cytokeratin 7, CA125 and MUC5AC. The lymphatic vascular density was increased among primary tumors. However, after multivariate analysis, the best predictors of a secondary tumor were a size of 10.0 cm or less, bilaterality and cytokeratin 7 negativity. Lack of MUC2 expression was an important factor excluding metastasis. CONCLUSIONS: The higher intratumoral lymphatic vascular density in primary tumors when compared with secondary lesions suggests differences in the microenvironment. However, considering the differential diagnosis, the best discriminator of a secondary tumor is the combination of tumor size, laterality and the pattern of expression of cytokeratin 7 and MUC2. .


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Middle Aged , Young Adult , Adenocarcinoma, Mucinous/pathology , Adenocarcinoma, Mucinous/secondary , Lymphatic Vessels/pathology , Ovarian Neoplasms/pathology , Adenocarcinoma, Mucinous/chemistry , /analysis , Diagnosis, Differential , Immunohistochemistry , Keratins/analysis , Lymphatic Metastasis , Lymphatic Vessels/chemistry , Membrane Glycoproteins/analysis , Membrane Proteins/analysis , Mucins/analysis , Ovarian Neoplasms/chemistry , Reference Values , Tissue Array Analysis , Tumor Burden , Biomarkers, Tumor/analysis
2.
Article in English | IMSEAR | ID: sea-138770

ABSTRACT

Background & objectives: Concentric lamellar calcifications known as psammoma bodies (PB) are found in benign and malignant tumours. Whether or not the inorganic element concentrations in psammomas are similar to serous adenocarcinoma of the ovary and thyroid papillary cancer tissues has not yet been ascertained. We undertook this retrospective study to establish if there is any difference in the concentrations of inorganic ions found in psammomas in serous adenocarcinoma of the ovary, and those found in thyroid papillary cancer tissue. Methods: PB samples from patients with adenocarcinoma of the ovary (n = 10) and with thyroid papillary cancer (n = 10) were analyzed through inductively-coupled plasma spectroscopy (ICP). Results: There were no significant differences in the concentrations of inorganic elements in PB from thyroid papillary cancer than in those PB from ovarian cancer. Interpretation & conclusions: Differences in the concentrations of inorganic elements may be due to the variation in environmental pollution. Our study had limitation of small sample size. Our results suggest that some inorganic elements can participate in the origin of psammoma bodies.


Subject(s)
Adenocarcinoma/chemistry , Carcinoma , Female , Humans , Inorganic Chemicals/analysis , Ions/analysis , Ovarian Neoplasms/chemistry , Thyroid Neoplasms/chemistry
3.
Rev. méd. Chile ; 140(1): 93-97, ene. 2012. ilus
Article in Spanish | LILACS | ID: lil-627614

ABSTRACT

Male accessory sexual glands arising in ovarian cystic teratoma are exceedingly rare. We report a 56-year-old female subjected to an ovariohysterectomy due to a left ovarian mass. The pathological study of the surgical piece revealed a tumor composed of different mature tissue elements and well defined nodules of benign prostatic tissue.


Subject(s)
Female , Humans , Male , Middle Aged , Dermoid Cyst/pathology , Ovarian Neoplasms/pathology , Prostate/pathology , Teratoma/pathology , Dermoid Cyst/chemistry , Ovarian Neoplasms/chemistry , Prostate-Specific Antigen/analysis , Prostate/chemistry , Protein Tyrosine Phosphatases/analysis , Teratoma/chemistry
4.
Rev. Fac. Cienc. Méd. (Córdoba) ; 62(2,supl. 1): 59-66, 2005.
Article in Spanish | LILACS | ID: lil-441198

ABSTRACT

Las expectativas de vida han cambiado el manejo de la menopausia, etapa de la vida en la que la mujer presenta la mayor incidencia de cáncer. La terapia hormonal (TH) tiene en la actualidad indicaciones más acotadas y en particular en las pacientes que ya tuvieron cáncer. Las contraindicaciones oncológicas para el uso de TH son analizadas en relación a tumores hormono dependientes (endometrio y mama), a los con dependencia parcial (ovario y adenocarcinoma de cuello) y a los independientes (cuello,vulva y vagina).El cáncer colorectal, de alta mortalidad, se suponía protegido por TH, pero hoy no se puede confirmar esa observación. El aumento de incidencia y mortalidad del cáncer de mama es concluyente. La alta prevalencia de este tumor invita a ser cautelosos y advertidos en el diagnostico precoz en aquellas poblaciones mas expuestas. La TH combinada y por periodos de mas de la al1.0S demostró un incipiente incremento. Se esta en la búsqueda de hormonas selectivas que no estimulen los receptores en la mama y en el endometrio y que actúen favorablemente sobre otras áreas.


The life expectation has been changeable the manner of menopause handling. At the same time, the women after fifty have the highest incidence of cancer. The hormonal replacement therapy (HT) to date has very few indications for patients with cancer. The oncologic contraindication for HT are analysed in detail, particulary for breast tumour. At the present time, the studies and the metanalysis on HT and breast cancer not showed a quantitative increase on the risk. We are looking for selective hormone with antagonist for endometrium and breast receptors, and effectiveness on the others areas.


Subject(s)
Humans , Female , Hormone Replacement Therapy , Menopause , Neoplasms/chemically induced , Breast Neoplasms/chemically induced , Colorectal Neoplasms/chemically induced , Hormone Replacement Therapy/adverse effects , Ovarian Neoplasms/chemistry , Risk Factors , Selective Estrogen Receptor Modulators/therapeutic use
5.
Article in English | WPRIM | ID: wpr-95264

ABSTRACT

Mucinous neoplasms occur rarely in association with cystic teratoma, Sertoli-Leydig cell tumor, granulosa cell tumor or carcinoid tumor. Several cases of an ovarian stromal tumor with minor sex-cord elements have been reported in the literatures. However, there has been no report about an ovarian mucinous neoplasm coexisting with a stromal tumor with sex-cord elements yet. We report a case of an ovarian neoplasm composed of both mucinous cystadenoma and stromal tumor with minor sex-cord elements in a 58-yr-old female. The ovary including the mass measured 5 cm in size. On section, it revealed an unilocular cyst (4.5 cm in diameter) filled with mucinous fluid. There was a round, yellow, solid nodule, 1.5 cm in diameter within the wall. Microscopically, the cyst was lined by a single layer of endocervical mucinous epithelium and the nodule was composed of spindle cells showing an intersecting and whorled arrangement. There were cell nests showing polygonal shape with abundant cytoplasm among the spindle cells. They showed immunoreactivity for inhibin and did not have any connection with the adjacent mucinous epithelium. Therefore, we interpret the mucinous cystadenoma as having arisen de novo.


Subject(s)
Female , Humans , Cystadenoma, Mucinous/chemistry , Inhibins/analysis , Middle Aged , Ovarian Neoplasms/chemistry , Sertoli-Leydig Cell Tumor/pathology , Stromal Cells/pathology
6.
J Postgrad Med ; 2000 Jul-Sep; 46(3): 172-5
Article in English | IMSEAR | ID: sea-117489

ABSTRACT

AIMS: To find out the status of DNA, RNA and protein in human uterine, ovarian, breast and rectal carcinoma. MATERIAL AND METHODS: In this prospective study, patients of age group between late thirties and late fifties suffering from uterine, ovarian, breast and rectal cancer were taken as subjects of the present study. The total number of cases studied for each cases was ten. Pieces of human carcinomatous tissues of above mentioned cases were taken along with surrounding normal tissues. From the tissue samples, putrescine is separated by the method of Herbst et al, DNA analysed by Diphenylamine method, RNA by Orcinol method and protein by Biuret method. RESULTS: Tissue content of putrescine rises simultaneously with that of DNA, RNA and protein in carcinomatous growths as above in comparison to their respective adjacent normal tissue, the differences being statistically highly significant. CONCLUSIONS: Increase in DNA, RNA and protein concentration may be a pre-requisite for increased synthesis of putrescine in carcinomatous tissue and thereby the concentration of other di- and poly-amines.


Subject(s)
Adult , Biopsy, Needle , Breast Neoplasms/chemistry , Culture Techniques , DNA, Neoplasm/analysis , Female , Humans , Male , Middle Aged , Oncogene Proteins/analysis , Ovarian Neoplasms/chemistry , Probability , Prospective Studies , Putrescine/analysis , RNA, Neoplasm/analysis , Rectal Neoplasms/chemistry , Sensitivity and Specificity , Spectrophotometry , Biomarkers, Tumor/analysis , Uterine Neoplasms/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL